JoinStar Showcases Next-Generation Immunodiagnostic Innovations at the 23rd CACLP

Xiamen, March 21, 2026 — JoinStar Biomedical Technology Co., Ltd. proudly presented its latest comprehensive diagnostic solutions at the 23rd China Association of Clinical Laboratory Practice Expo (CACLP). Drawing significant attention from industry professionals, JoinStar highlighted its core mission of innovating diagnostics and empowering health.

The spotlight of the event was JoinStar’s advanced triple-immunodiagnostic portfolio, which includes the Jet-iStar platform, the iMatrix platform, and the CLIA platform. This comprehensive product matrix optimizes laboratory workflows and significantly reduces Turnaround Time (TAT). Through these platforms, JoinStar continues to deliver targeted clinical solutions across key areas, including infection, cardiovascular disease, allergy, gastrointestinal function, Alzheimer's disease, and chronic diseases.

01. The CLIA Platform: Revolutionizing with "True Whole Blood" Technology

The CLIA platform captivated attendees with its differentiated approach to urgent clinical diagnostics.

The platform features the groundbreaking "True Whole Blood" CLIA system.

This innovation allows for direct whole-blood processing without centrifugation, breaking the boundaries of traditional chemiluminescence to deliver exceptionally fast and accurate results.

The system supports a comprehensive assay menu covering critical areas such as cardiovascular diseases (CVD), Alzheimer's disease (AD), coagulation function, and gastrointestinal health.

02. The iMatrix Platform: High-Throughput Multiplex Liquid-Chip Innovation

Developed through eight years of intensive R&D to break international patent monopolies, the iMatrix platform represents a leap forward in multiplex testing.

The technology utilizes proprietary quantum dots "host-guest" encoding magnetic spheres.

This unique core microbead structure provides a larger specific surface area, delivering higher sensitivity and specificity for complex samples.

The system utilizes magnetic control for adsorption and separation, completely eliminating the need for centrifugation and thereby optimizing operational processes.

The platform's rapidly expanding menu includes advanced markers such as the Interleukin-2 Receptor (IL-2R), the Total IgE detection kit for comprehensive allergy screening, and the Food-specific IgG Antibody detection kit (20 Items).

03. The Jet-iStar Platform: Comprehensive Rapid Diagnostics

As a highly recognized semi-automatic immunofluorescence platform, Jet-iStar offers a versatile layout ranging from handheld point-of-care devices to fully automated assembly lines.

The platform meets urgent clinical demands with innovative combo assays, including the HBP/PCT test for sepsis early warning and antibiotic guidance.

It also features the CRP/SAA combo test for the differential diagnosis of bacterial and viral infections.

For specialized care, the menu includes the S100 protein for assessing central nervous system damage and G17 for the early screening of gastric cancer.

Expanding Horizons: At-Home Testing & AI-Powered Health Management

Beyond traditional laboratory settings, JoinStar is pioneering accessible health management for the general public.

Our portfolio includes innovative home-testing solutions targeting food sensitivity, alongside highly accurate, non-invasive colorectal cancer screening kits (utilizing fecal occult blood/transferrin dual-testing and SDC2 methylation technologies) that deliver results in minutes.

As an AI-powered chronic disease management solution provider, JoinStar has developed a data-driven ecosystem.

This AI model combines deep data mining with intelligent intervention to create a closed-loop system—transforming primary care by ensuring precise patient identification, efficient management, and sustainable operational growth for healthcare institutions.